Akston Biosciences

Beverly, United States

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.

Apr 2025

Series H

Biopharma Biotechnology Diabetes Veterinary

Top Investors

Propel(X)EQx Fund Cherrystone Angel Group National Institute of Diabetes and Digestive and Kidney Diseases Angel Healthcare Investors

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Akston Biosciences

Who are Akston Biosciences's investors?

Akston Biosciences's investors include Propel(X), EQx Fund, Cherrystone Angel Group, National Institute of Diabetes and Digestive and Kidney Diseases, Angel Healthcare Investors.

Where is Akston Biosciences headquartered?

Akston Biosciences is headquartered in Beverly, United States.

What does Akston Biosciences do?

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.

What stage is Akston Biosciences at?

Akston Biosciences is at the Series H stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2025.

MLA

"Akston Biosciences — Funding & Investors." VCBacked, April 30, 2025, https://www.vcbacked.co/company/akston-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2025). Akston Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/akston-biosciences

Wikipedia (cite web)

{{cite web |title=Akston Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/akston-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2025.